These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2822067)

  • 1. Pharmacokinetics of pentopril in the elderly.
    Rakhit A; Kochak GM; Tipnis V; Radensky P; Hurley ME; Williams R
    Br J Clin Pharmacol; 1987 Sep; 24(3):351-7. PubMed ID: 2822067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of pentopril, a new angiotensin-converting-enzyme inhibitor in humans.
    Rakhit A; Hurley ME; Tipnis V; Coleman J; Rommel A; Brunner HR
    J Clin Pharmacol; 1986 Mar; 26(3):156-64. PubMed ID: 3007583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of renal impairment on disposition of pentopril and its active metabolite.
    Rakhit A; Radensky P; Szerlip HM; Kochak GM; Audet PR; Hurley ME; Feldman GM
    Clin Pharmacol Ther; 1988 Jul; 44(1):39-48. PubMed ID: 3391004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of trandolapril after repeated administration of 2 mg to young and elderly patients with mild-to-moderate hypertension.
    Arner P; Wade A; Engfeldt P; Mouren M; Stepniewski JP; Sultan E; Bryce T; Lenfant B
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S44-9. PubMed ID: 7527101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of renal clearance of furosemide by pentopril, an angiotensin-converting enzyme inhibitor.
    Rakhit A; Kochak GM; Tipnis V; Hurley ME
    Clin Pharmacol Ther; 1987 May; 41(5):580-6. PubMed ID: 3032491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the pharmacokinetics and pharmacodynamics of oral doses of perindopril in normotensive Chinese and Caucasian volunteers.
    Anderson PJ; Critchley JA; Tomlinson B; Resplandy G
    Br J Clin Pharmacol; 1995 Apr; 39(4):361-8. PubMed ID: 7640141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacokinetic study of cilazapril in elderly and young volunteers.
    Williams PE; Brown AN; Rajaguru S; Walters GE; McEwen J; Durnin C
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):211S-215S. PubMed ID: 2527535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of the ace inhibitor benazepril hydrochloride in the elderly.
    Kaiser G; Ackermann R; Dieterle W; Durnin CJ; McEwen J; Ghose K; Richens A; Holmes IB
    Eur J Clin Pharmacol; 1990; 38(4):379-85. PubMed ID: 2344861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis.
    Tsai HH; Lees KR; Howden CW; Reid JL
    Br J Clin Pharmacol; 1989 Jul; 28(1):53-9. PubMed ID: 2550045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of age on the pharmacokinetics and pharmacodynamics of perindopril.
    Lees KR; Green ST; Reid JL
    Clin Pharmacol Ther; 1988 Oct; 44(4):418-25. PubMed ID: 2844467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of quinapril on angiotensin converting enzyme and plasma renin activity as well as pharmacokinetic parameters of quinapril and its active metabolite, quinaprilat, after intravenous and oral administration to mature horses.
    Davis JL; Kruger K; LaFevers DH; Barlow BM; Schirmer JM; Breuhaus BA
    Equine Vet J; 2014 Nov; 46(6):729-33. PubMed ID: 24175935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of food on the bioavailability of pentopril, an angiotensin-converting-enzyme inhibitor, in healthy subjects.
    Rakhit A; Hurley ME; Redalieu E; Kochak G; Tipnis V; Coleman J; Rommel A
    J Clin Pharmacol; 1985 Sep; 25(6):424-8. PubMed ID: 2997306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and tolerability of a new manidipine and delapril fixed oral combination in young and elderly subjects.
    Stockis A; De Bruyn S; Gengler C; Goethals F; Lens S; Poli G; Acerbi D
    Arzneimittelforschung; 2003; 53(8):554-61. PubMed ID: 13677245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the angiotensin-converting-enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, in dog.
    King JN; Maurer M; Morrison CA; Mauron C; Kaiser G
    Xenobiotica; 1997 Aug; 27(8):819-29. PubMed ID: 9293618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degrees of renal insufficiency.
    Verpooten GA; Genissel PM; Thomas JR; De Broe ME
    Br J Clin Pharmacol; 1991 Aug; 32(2):187-92. PubMed ID: 1657092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of M100240 and MDL 100,173, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy young and elderly volunteers.
    Emmons GT; Argenti R; Martin LL; Martin NE; Jensen BK
    J Clin Pharmacol; 2004 Aug; 44(8):901-5. PubMed ID: 15286094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure.
    Sennesael J; Ali A; Sweny P; Vandenburg M; Slovic D; Dratwa M; Resplandy G; Genissel P; Desche P
    Br J Clin Pharmacol; 1992 Jan; 33(1):93-9. PubMed ID: 1311597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of rizatriptan in healthy elderly subjects.
    Musson DG; Birk KL; Panebianco DL; Gagliano KD; Rogers JD; Goldberg MR
    Int J Clin Pharmacol Ther; 2001 Oct; 39(10):447-52. PubMed ID: 11680669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administrations to dogs.
    King JN; Mauron C; Kaiser G
    Am J Vet Res; 1995 Dec; 56(12):1620-8. PubMed ID: 8599524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of pentopril, a new orally active angiotensin-converting enzyme inhibitor, and its active metabolite in rats.
    Rakhit A; Kochak G; Dotson R; Tipnis V
    J Pharm Sci; 1985 Sep; 74(9):947-52. PubMed ID: 2999376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.